Abstract: Provided is an antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, wherein the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune-related disorders, such as tumors. A polynucleotide encoding the antibody or antigen-binding fragment thereof and a pharmaceutical composition comprising the antibody or antigen binding fragment thereof are also provided.

Abstract: The present disclosure relates to a combination of an FAK inhibitor, an immunogenic cell death inducer, and an immune checkpoint inhibitor for the treatment of a tumor. The present disclosure also relates to a combination of an FAK inhibitor and an immunogenic cell death inducer for the treatment of a tumor.

Abstract: The present disclosure relates to the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of tumors.

Abstract: The present disclosure relates to the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of tumors.

Abstract: An antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune-related disorders, such as tumors.

Abstract: The present invention discloses a rare-earth sulfide colorant and a preparation method thereof. The chemical formula of the rare-earth sulfide colorant of the present invention is RE2-2xS3-3x.2y [REPO4], wherein RE is selected from one or more of La, Ce, Pr, Nd and Sm, and the ratio of y to x is 0.001 to 0.65. The present invention also discloses use of a phosphorus-containing compound for increasing the vividness of a rare-earth sulfide colorant.

Abstract: The present invention discloses a rare-earth sulfide colorant and a preparation method thereof. The chemical formula of the rare-earth sulfide colorant of the present invention is RE2-2xS3-3x.2y [REPO4], wherein RE is selected from one or more of La, Ce, Pr, Nd and Sm, and the ratio of y to x is 0.001 to 0.65. The present invention also discloses use of a phosphorus-containing compound for increasing the vividness of a rare-earth sulfide colorant.

Abstract: This invention provides an orange-yellow-emitting phosphor, the preparation method and the use thereof. This orange-yellow-emitting phosphor has a general formula represented by formula I: Sr9?a?b?xMaMg1.5+b(PO4)7:xEu2+??formula I wherein in formula I, said M is one or two of Ca and Ba; and 0.001?x?0.9, 0?a?1.0, 0?b?2.3. This orange-yellow-emitting phosphor uses a phosphate as the host material and Eu2+ ions as activation ions. The chemical properties of the phosphor are stable. The phosphor has relatively wide excitation band and emission band. And the red component in its emission spectrum is abundant, therefore, coupling the blue InGaN chip with the orange-yellow-emitting phosphor provided by this invention can obtain warm white light. The phosphor is radiation free, therefore, it will not be harmful to the environment.

Abstract: This invention provides an orange-yellow-emitting phosphor, the preparation method and the use thereof. This orange-yellow-emitting phosphor has a general formula represented by formula I: Sr9?a?b?xMaMg1.5+b(PO4)7:xEu2+ formula I; wherein in formula I, said M is one or two of Ca and Ba; and 0.001?x?0.9, 0?a?1.0, 0?b?2.3. This orange-yellow-emitting phosphor uses a phosphate as the host material and Eu2+ ions as activation ions. The chemical properties of the phosphor are stable. The phosphor has relatively wide excitation band and emission band. And the red component in its emission spectrum is abundant, therefore, coupling the blue InGaN chip with the orange-yellow-emitting phosphor provided by this invention can obtain warm white light. The phosphor is radiation free, therefore, it will not be harmful to the environment.